Skip to content
Back to Investors
FS

Fine Structure Ventures

Venture Capital

Portfolio

2

companies

By category

  • Uncategorised£43.3M
  • FoodTech£19.6M

By location

  • United Kingdom£43.3M
  • London£19.6M

Portfolio companies

CB

Constructive Bio

Constructive Bio rewrites genomes to turn living cells into sustainable biofactories.

HF

Hoxton Farms

Hoxton Farms produces cultivated animal fat to improve meat alternatives.


Team

JU

Jennifer Uhrig

Partner

SK

Shyam Kamadolli

Managing Director


Recent investments

Series A
$58.0M

The Series A round was led by Ahren, OMX Ventures, and Paladin Capital Group to develop biomanufacturing platforms.

"Synthetic genomics is redefining how we harness biology. Our suite of proprietary technologies and incomparable team allows us to build novel materials and products that will revolutionise drug manufacturing and discovery,"
— Ola Wlodek, CEO
Series A
$22.0M

Collaborative Fund and Fine Structure Ventures led the round to support the scale up of cultivated fat manufacturing.

"At Hoxton Farms, we are obsessed with fat. Fat is the single most important sensory component in all of the meat that we eat. Using cultivated fat alongside plant proteins, we have shown that we can make products with the juiciness and flavour that plant-based meat has been missing. We’re now building our pilot plant in central London so that we can show visitors a new way of making the same delicious meat."
— Max Jamilly, Co-founder